Gastrointestinal Stromal Tumor With Multiple Primary Tyrosine Kinase Mutations-Clinicopathologic and Molecular Characterization

被引:4
作者
Wong, Newton A. C. S. [1 ]
Taniere, Philippe [2 ]
Walsh, Shaun [3 ]
Wallace, Andrew [4 ]
Nonaka, Daisuke [5 ]
Jones, Thomas [6 ]
Gonzalez, David [7 ]
机构
[1] Southmead Hosp, Dept Cellular Pathol, Pathol Sci Bldg,Southmead Rd, Bristol BS10 5NB, Avon, England
[2] Queen Elizabeth Hosp, Dept Cellular Pathol, Birmingham, W Midlands, England
[3] Ninewells Hosp & Med Sch, Dept Pathol, Dundee, Scotland
[4] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Genom Diagnost Lab, Manchester, Lancs, England
[5] Christie Hosp, Dept Histopathol, Manchester, Lancs, England
[6] Royal Marsden NHS Fdn Trust, Ctr Mol Pathol, London, England
[7] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland
关键词
GIST; KIT; PDGFRA; mutation; genetic heterogeneity; next generation sequencing; PDGFRA MUTATIONS; IMATINIB; GIST; KIT;
D O I
10.1097/PAI.0000000000000660
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
A unique cohort of chemo-naive gastrointestinal stromal tumors (GISTs) with double-primary tyrosine kinase mutations was characterized particularly to determine whether coexistent mutations represent a single mutational event. Up to 2013, 4 UK centers reported 9 GISTs with 2 primary tyrosine kinase mutations. In each of 8 cases validated by next generation sequencing, both mutations were present in the same allele of the same exon (KIT exon 11 or 17, or PDGFRA exon 18). One case showed the second mutation only on some of the mutant alleles. Seven cases showed both mutations in all the reads, but in 2 cases, additional variants were found only in some reads. Clinicopathologic features of the 8 cases were similar to GISTs with single-primary mutations. When GIST genotyping rarely uncovers multiple tyrosine kinase variants in an exon, they occur in the same allele but are likely to represent separate mutational events and lack clinical significance.
引用
收藏
页码:461 / 465
页数:5
相关论文
共 50 条
  • [21] Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors
    Ken-Hong Lim
    Ming-Jer Huang
    Li-Tzong Chen
    Tsang-En Wang
    Chien-Liang Liu
    Cheng-Shyong Chang
    Mei-Chin Liu
    Reuy-Kuen Hsieh
    Chin-Yuan Tzen
    [J]. Medical Oncology, 2008, 25 : 207 - 213
  • [22] Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors
    Lim, Ken-Hong
    Huang, Ming-Jer
    Chen, Li-Tzong
    Wang, Tsang-En
    Liu, Chien-Liang
    Chang, Cheng-Shyong
    Liu, Mei-Chin
    Hsieh, Reuy-Kuen
    Tzen, Chin-Yuan
    [J]. MEDICAL ONCOLOGY, 2008, 25 (02) : 207 - 213
  • [23] Identification of New Tumor-Related Gene Mutations in Chinese Gastrointestinal Stromal Tumors
    Feng, Yuyang
    Yao, Surui
    Pu, Zhening
    Cheng, Han
    Fei, Bojian
    Zou, Jian
    Huang, Zhaohui
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [24] Tyrosine Kinase Inhibition Activates Intratumoral γδ T Cells in Gastrointestinal Stromal Tumor
    Etherington, Mark S.
    Hanna, Andrew N.
    Medina, Benjamin D.
    Liu, Mengyuan
    Tieniber, Andrew D.
    Kwak, Hyunjee V.
    Tardy, Katherine J.
    Levin, Lillian
    Do, Kevin J.
    Rossi, Ferdinando
    Zeng, Shan
    Dematteo, Ronald P.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2024, 12 (01) : 107 - 119
  • [25] Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells
    Berglund, Erik
    Ubhayasekera, Sarojini Jayantha Kumari A.
    Karlsson, Fredrik
    Akcakaya, Pinar
    Aluthgedara, Warunika
    Ahlen, Jan
    Frobom, Robin
    Nilsson, Inga-Lena
    Lui, Weng-Onn
    Larsson, Catharina
    Zedenius, Jan
    Bergquist, Jonas
    Branstrom, Robert
    [J]. ANTI-CANCER DRUGS, 2014, 25 (04) : 415 - 422
  • [26] MOLECULAR-GENETIC BASIS OF GASTROINTESTINAL STROMAL TUMOR PERSONALIZED THERAPY BY RECEPTOR TYROSINE KINASE INHIBITORS (A REVIEW)
    Kozinova, M. T.
    Abalakov, G. A.
    Sharipova, D., V
    Shimanovsky, N. L.
    [J]. PHARMACEUTICAL CHEMISTRY JOURNAL, 2021, 55 (04) : 315 - 322
  • [27] Molecular-Genetic Basis of Gastrointestinal Stromal Tumor Personalized Therapy by Receptor Tyrosine Kinase Inhibitors (A Review)
    M. T. Kozinova
    G. A. Abalakov
    D. V. Sharipova
    N. L. Shimanovsky
    [J]. Pharmaceutical Chemistry Journal, 2021, 55 : 315 - 322
  • [28] Multiple liver abscess formation and primary gastrointestinal stromal tumor
    Chang, Amy E.
    Mann, Gary N.
    Hoch, Benjamin
    Loggers, Elizabeth T.
    Pollack, Seth M.
    Kolokythas, Orpheus
    Jones, Robin L.
    [J]. RARE TUMORS, 2013, 5 (03) : 167 - 168
  • [29] New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
    Serrano, Cesar
    Bauer, Sebastian
    [J]. CURRENT ONCOLOGY REPORTS, 2022, 24 (02) : 151 - 159
  • [30] New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
    César Serrano
    Sebastian Bauer
    [J]. Current Oncology Reports, 2022, 24 : 151 - 159